A Single-Dose Malaria Cure Passed Its Biggest Test in Mozambique. Resistance Is the Next Worry.
In a trial of 3,400 children, one dose of the experimental drug ganaquine cured as many infections as the standard three-day course, a result that could transform treatment in places where completing a course is the hardest part.

